06.11.2014 • News • AkzoNobel • powder coatings plant • Powder Coatings

AkzoNobel Starts Powder Coatings Plant in Dubai

AkzoNobel has started up its new powder coatings plant in Dubai, United Arab Emirates. Without giving detail, the Dutch group said the facility will "significantly increase capacity" for its Interpon and Resicoat products.

The new plant targets what AkzoNobel said is growing regional demand for decorative powder coatings - particularly from the architectural sector - as well as functional products used in the oil and gas and construction markets.

AkzoNobel has been lifting its profile in the Middle East with a series of strategic investments. In 2013, it acquired a 50% stake and management control in Sadolin Paints Oman, a manufacturer of decorative paints and performance coatings.

Peter Tomlinson, managing director of AkzoNobel Middle East, said the new plant in Dubai "underlines our commitment to the Middle East, where our aim is to continue to outgrow our competitors."

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Top-Feature

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.